Annual Working Capital
$1.86 M
-$1.51 M-44.84%
December 31, 2023
Summary
- As of February 23, 2025, BDRX annual working capital is $1.86 million, with the most recent change of -$1.51 million (-44.84%) on December 31, 2023.
- During the last 3 years, BDRX annual working capital has fallen by -$6.71 million (-78.27%).
- BDRX annual working capital is now -95.85% below its all-time high of $44.82 million, reached on December 1, 2014.
Performance
BDRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$5.11 M
+$3.25 M+174.75%
June 1, 2024
Summary
- As of February 23, 2025, BDRX quarterly working capital is $5.11 million, with the most recent change of +$3.25 million (+174.75%) on June 1, 2024.
- Over the past year, BDRX quarterly working capital has dropped by -$1.17 million (-18.61%).
- BDRX quarterly working capital is now -88.59% below its all-time high of $44.82 million, reached on December 1, 2014.
Performance
BDRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BDRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.8% | -18.6% |
| 3 y3 years | -78.3% | +51.6% |
| 5 y5 years | -53.4% | +51.6% |
BDRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.1% | at low | -61.8% | +174.8% |
| 5 y | 5-year | -86.1% | at low | -61.8% | +174.8% |
| alltime | all time | -95.8% | at low | -88.6% | +174.8% |
Biodexa Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $5.11 M(+174.7%) |
| Dec 2023 | $1.86 M(-44.8%) | $1.86 M(-70.4%) |
| Jun 2023 | - | $6.28 M(+86.2%) |
| Dec 2022 | $3.37 M(-74.8%) | $3.37 M(-60.5%) |
| Jun 2022 | - | $8.54 M(-36.2%) |
| Dec 2021 | $13.39 M(+56.3%) | $13.39 M(+203.6%) |
| Jun 2021 | - | $4.41 M(-48.5%) |
| Dec 2020 | $8.57 M(-19.0%) | $8.57 M(+138.2%) |
| Jun 2020 | - | $3.60 M(-66.0%) |
| Dec 2019 | $10.58 M | $10.58 M(-23.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $13.85 M(+246.8%) |
| Dec 2018 | $3.99 M(-71.1%) | $3.99 M(-78.4%) |
| Jun 2018 | - | $18.52 M(+34.1%) |
| Dec 2017 | $13.81 M(-13.2%) | $13.81 M(+138.2%) |
| Jun 2017 | - | $5.80 M(-63.6%) |
| Dec 2016 | $15.92 M(-4.3%) | $15.92 M(+255.7%) |
| Jun 2016 | - | $4.48 M(-73.1%) |
| Dec 2015 | $16.64 M(-62.9%) | $16.64 M(-54.9%) |
| Jun 2015 | - | $36.88 M(-17.7%) |
| Dec 2014 | $44.82 M(+1410.0%) | $44.82 M |
| Dec 2013 | $2.97 M | - |
FAQ
- What is Biodexa Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual working capital year-on-year change?
- What is Biodexa Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals quarterly working capital year-on-year change?
What is Biodexa Pharmaceuticals annual working capital?
The current annual working capital of BDRX is $1.86 M
What is the all time high annual working capital for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual working capital is $44.82 M
What is Biodexa Pharmaceuticals annual working capital year-on-year change?
Over the past year, BDRX annual working capital has changed by -$1.51 M (-44.84%)
What is Biodexa Pharmaceuticals quarterly working capital?
The current quarterly working capital of BDRX is $5.11 M
What is the all time high quarterly working capital for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high quarterly working capital is $44.82 M
What is Biodexa Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, BDRX quarterly working capital has changed by -$1.17 M (-18.61%)